Workflow
Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
AMPHAmphastar Pharmaceuticals(AMPH) ZACKS·2025-02-28 00:30

Amphastar Pharmaceuticals (AMPH) reported 186.52millioninrevenueforthequarterendedDecember2024,representingayear−over−yearincreaseof4.7186.52 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.7%. EPS of 0.92 for the same period compares to 0.88ayearago.Thereportedrevenuerepresentsasurpriseof−1.080.88 a year ago.The reported revenue represents a surprise of -1.08% over the Zacks Consensus Estimate of 188.55 million. With the consensus EPS estimate being $0.96, the EPS surprise was -4.17%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...